List of ArisGlobal LifeSphere MultiVigilance Customers
ArisGlobal
201 Jones Road, 3rd FL East,
Waltham, 2451, MA,
United States
Waltham, 2451, MA,
United States
1 609-360-4042
Professional Services
1700
$250M
Since 2010, our global team of researchers has been studying ArisGlobal LifeSphere MultiVigilance customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased ArisGlobal LifeSphere MultiVigilance for Environment, Health and Safety (EHS) from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using ArisGlobal LifeSphere MultiVigilance for Environment, Health and Safety (EHS) include: AbbVie, a United States based Life Sciences organisation with 55000 employees and revenues of $56.33 billion, Teva Pharmaceuticals, a Israel based Life Sciences organisation with 35001 employees and revenues of $15.85 billion, U.S. Food And Drug Administration, a United States based Government organisation with 19116 employees and revenues of $7.20 billion, Medac, a Germany based Life Sciences organisation with 2000 employees and revenues of $600.0 million, Montreal Health Innovations Coordinating Center (MHICC), a Canada based Professional Services organisation with 100 employees and revenues of $10.0 million and many others.
Contact us if you need a completed and verified list of companies using ArisGlobal LifeSphere MultiVigilance, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the ERP Services and Operations software purchases.
The ArisGlobal LifeSphere MultiVigilance customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of ERP Services and Operations software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AbbVie | Life Sciences | 55000 | $56.3B | United States | ArisGlobal | ArisGlobal LifeSphere MultiVigilance | Environment, Health and Safety (EHS) | 2018 | n/a |
In 2018, AbbVie implemented ArisGlobal LifeSphere MultiVigilance, deploying a Platform for Individual Case Safety Report to support its pharmacovigilance and safety operations. The implementation used ArisGlobal as the vendor and aligns with LifeSphere MultiVigilance positioning as a next generation, end to end safety system developed in close partnership with industry stakeholders including the FDA, Boehringer Ingelheim, Teva and AbbVie.
The ArisGlobal LifeSphere MultiVigilance deployment focused on core pharmacovigilance capabilities common to Platform for Individual Case Safety Report solutions, including structured case intake, triage and case processing, medical coding, expedited regulatory reporting and aggregate safety reporting. Configuration work emphasized ICSR lifecycle management and workflow orchestration to standardize case handling, automate rule based routing and support consistent safety data capture across intake channels.
The implementation connected the safety platform to AbbVie operational data sources and regulatory submission channels, enabling end to end management of individual case safety reports within existing safety operations. Operational coverage targeted AbbVie pharmacovigilance and clinical safety teams, with the platform serving as the centralized ICSR repository and operational control point for case progression and reporting workflows.
Governance and process alignment accompanied the technical rollout, with emphasis on standardized case processing workflows, role based access and audit capable reporting to support regulatory compliance. The deployment reflected vendor momentum in 2018 for LifeSphere MultiVigilance and positioned AbbVie to leverage a modern Platform for Individual Case Safety Report for ongoing safety operations.
|
 |
Medac | Life Sciences | 2000 | $600M | Germany | ArisGlobal | ArisGlobal LifeSphere MultiVigilance | Environment, Health and Safety (EHS) | 2023 | n/a |
In 2023 Medac implemented ArisGlobal LifeSphere MultiVigilance as part of a broader adoption of ArisGlobal LifeSphere Safety solutions to modernize its drug safety processes. ArisGlobal LifeSphere MultiVigilance is deployed as a Platform for Individual Case Safety Report alongside LifeSphere Reporting and Analytics and EV Triage to create a unified safety technology stack for automated case processing and safety signal analysis.
The implementation centers on automated case intake and processing capabilities provided by LifeSphere MultiVigilance, supplemented by Reporting and Analytics for aggregate safety reporting and EV Triage for prioritized event evaluation. The deployment leverages artificial intelligence and analytics for intelligent triage, coding assistance, and workflow automation, and it is configured to support end to end pharmacovigilance case lifecycle management consistent with the Platform for Individual Case Safety Report functional model.
Operational ownership is positioned within Global Pharmacovigilance and will cover medac sites including Wedel and Tornesch while supporting medac’s global safety monitoring obligations for its oncology, hematology, urology, and autoimmune therapy portfolios. The rollout is scoped to centralize adverse event management and to standardize case workflows across safety teams, enabling consistent safety review, reporting and analytics across regions where medac operates.
Governance changes focus on process digitization and automation of adverse event management to enable more intelligent safety analysis and to meet global compliance requirements stated for LifeSphere Safety. Medac states the initiative aims to minimize treatment risks for patients and to make pharmacovigilance processes smarter and more efficient, outcomes aligned with the capabilities of ArisGlobal LifeSphere MultiVigilance and the complementary Reporting and Analytics and EV Triage modules.
|
 |
Montreal Health Innovations Coordinating Center (MHICC) | Professional Services | 100 | $10M | Canada | ArisGlobal | ArisGlobal LifeSphere MultiVigilance | Environment, Health and Safety (EHS) | 2024 | n/a |
In 2024, Montreal Health Innovations Coordinating Center implemented ArisGlobal LifeSphere MultiVigilance as a Platform for Individual Case Safety Report to expand its service offering into post-market pharmacovigilance for biopharma clients. The implementation aligns with MHICC’s strategic move to add safety services alongside its existing pre-market clinical activities and is provisioned via ArisGlobal’s cloud CRO partnership model to provide on-demand access and configuration flexibility.
ArisGlobal LifeSphere MultiVigilance was deployed together with Reporting & Analytics, establishing an end-to-end automation-based safety platform that supports standard case intake, case processing workflows, regulatory reporting, and analytics. The configuration emphasizes workflow automation and next-generation generative AI capabilities for accelerated adverse event case processing, while Reporting & Analytics provides structured safety data views and analytics to support signal evaluation and client reporting.
Operational coverage centers on MHICC’s pharmacovigilance activities offered to multinational pharmaceutical and biotech clients, complementing the CRO’s clinical services across therapeutic areas including cardiology, oncology, neurology, gastroenterology, and endocrinology. The cloud deployment model was used to enable rapid provisioning and tailored capability sets appropriate to a CRO operating across academic and commercial sponsor engagements, without embedding unnecessary features.
Governance and rollout were described as collaborative and tailored, with ArisGlobal working closely with MHICC to configure the ideal combination of capabilities for a CRO workflow, preserving flexibility while standardizing safety case management processes. The stated outcome of the implementation is enabling MHICC to bring new safety services to market while leveraging automation and Reporting & Analytics to improve operational efficiency and differentiation in its pharmacovigilance proposition.
|
 |
|
Life Sciences | 35001 | $15.8B | Israel | ArisGlobal | ArisGlobal LifeSphere MultiVigilance | Environment, Health and Safety (EHS) | 2018 | n/a |
|
|
|
|
Government | 19116 | $7.2B | United States | ArisGlobal | ArisGlobal LifeSphere MultiVigilance | Environment, Health and Safety (EHS) | 2018 | n/a |
|
Showing 1 to 5 of 5 entries
Buyer Intent: Companies Evaluating ArisGlobal LifeSphere MultiVigilance
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating ArisGlobal LifeSphere MultiVigilance. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating ArisGlobal LifeSphere MultiVigilance for Environment, Health and Safety (EHS) include:
- Amala Partners, a France based Banking and Financial Services organization with 50 Employees
- Abacus.Ai, a United States based Professional Services company with 160 Employees
- 1-800-Flowers.com, a United States based Retail organization with 4000 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD ArisGlobal LifeSphere MultiVigilance Coverage
ArisGlobal LifeSphere MultiVigilance is a Environment, Health and Safety (EHS) solution from ArisGlobal.
Companies worldwide use ArisGlobal LifeSphere MultiVigilance, from small firms to large enterprises across 21+ industries.
Organizations such as AbbVie, Teva Pharmaceuticals, U.S. Food And Drug Administration, Medac and Montreal Health Innovations Coordinating Center (MHICC) are recorded users of
ArisGlobal LifeSphere MultiVigilance for Environment, Health and Safety (EHS).
Companies using ArisGlobal LifeSphere MultiVigilance are most concentrated in Life Sciences, Government and Professional Services, with adoption spanning over 21 industries.
Companies using ArisGlobal LifeSphere MultiVigilance are most concentrated in United States, Israel and Germany, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of ArisGlobal LifeSphere MultiVigilance across Americas, EMEA, and APAC.
Companies using ArisGlobal LifeSphere MultiVigilance range from small businesses with 0-100 employees - 20%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 20%, and global enterprises with 10,000+ employees - 60%.
Customers of ArisGlobal LifeSphere MultiVigilance include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified ArisGlobal LifeSphere MultiVigilance customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Environment, Health and Safety (EHS).